HBV Cure in India
HOO-IMM PLUS anti-virus treatment for patients with severe and incurable Hepatitis B infection focuses on preventing the spread of the virus and prevents DNA Polymerase from the HBV virus in combination with many other HBV targ drugs that can prevent re-infection and protect healthy hepatocyte liver cells open up new natural treatment options without any of the side effects of HBV-infected people.
HBV Treatment Failed:
There are many anti-viruses currently available for HBV treatment including IFN alpha, Lamuvidine, Entecavir, Telbibudine, and Tenofovir.
Interferon treatment has limited effectiveness, low performance, and often causes side effects.
Common side effects include fever, pain, diarrhea, vomiting, feelings of depression, rash, insomnia.
HOO-IMM PLUS, a herbal formula confirms the effective action of multiple anti-HBV, anti-Hepatocellular Carcinoma (HCC), and Hepatoprotective agents.
Anti – hbv
HOO-IMM PLUS HBV activity has been reported by many Ayush therapists in India and pharmacists from Africa. HOO-IMM PLUS has been studied extensively for Hepatitis B Virus treatment with inhibition of HBsAg cell secretion PLC / PRF / 5 and inhibition of Hepato carcinoma in the HepG2 cell line.
In clinical patients receiving Hooimm plus reported Target is not available in the Hepatitis B DNA Quantitative.
Chemopreventive HOO-IMM PLUS – Anti-Hepatocellular Carcinoma (HCC)
HOO-IMM PLUS forms a curcumin molecule that has been proven to be an astronomical key molecule in the prevention of hepatocellular carcinoma. Many studies have been done with curcumin suggesting that it prevents the progression of apoptosis, which may reduce ROS.
Here we have a different Curcuma longa extract system that produces curcumin with a higher degree of availability and other herbal extracts that improve intestinal curcumin absorption.
Hooimm Plus prevents liver damage in viral hepatitis. HBV people who receive Hooimm and treatment have a normal liver enzyme. The treatment forecast reports a standardized test of Serum Alanine Aminotransferase (ALT) or serum glutamic pyruvic transaminase (SGPT) and Aspartate Aminotransferase (AST).
AST and SGPT are blood tests that diagnose liver damage. SGPT and AST levels in the blood rise if your liver is damaged.
Biomarker or Protocol Protocol involved in anti-hbv treatment with Hooimm plus: –
- HBV Serological symptoms including HBsAg & HBeAg Elisa.
- Serum Alanine Aminotransferase (ALT) or Serum glutamic pyruvic transaminase (SGPT) and Aspartate Aminotransferase (AST) or SGOT.
- Load of HBV DNA Quantification-Viral Load.
Note: Quantification for HBV DNA shows viral load which plays a very important role in determining the stage of infection, determining treatment and finding the response to viral treatment. This test is highly recommended in the Chronic HBV- World Health Organization (WHO)
HOO-IMM Plus is a combination of herbal remedies for treating HIV and HBV infection marketed by HOOTONE REMEDIES. The capsule formulation contains 750 mg extracted from 10 different plant species
Each dose of 750 mg contains: –
|Muleti Ext||Glycyrrhiza glabra||75 MG|
|Bhui Amlaki Ext||Phyllanthus Niruri||75 MG|
|Harda Ext||Terminalia Chebula||75 MG|
|Bhojpatra Ext||Betula Utilis||75 MG|
|Punnaga Ext||Callophyllum Inophyllum||75 MG|
|Haldi Ext||Curcuma Longa||75 MG|
|Kalmegh Ext||Andrographis Paniculata||75 MG|
|Karela Beej Ext||Memordica Charantia||75 MG|
|Bichu Buti Ext||Urtica dioica||75 MG|
|Nirgundi Ext||Justica Gendarussa||75 MG|
Glycyrrhizin, a major component of the drug (licorice), has been widely used in the treatment of chronic hepatitis B in Japan.
Its effects on the secretion of hepatitis B surface antigen (HBsAg) were tested in vitro. Glycyrrhizin suppressed HBsAg fluid and accumulated it in doses to the PLC / PRF / 5 cells.
The aqueous extraction of the plant Phyllanthus niruri inhibits the chronic DNA polymerase of the hepatitis B virus and binds to the surface of the hepatitis B virus antigen in vitro.
The potential anti-HBV agent, ellagic acid, was isolated from the plant drug P. niruri, and its physicochemical properties.
Phyllanthus niruri (Bhumyamalaki) had the ability to inhibit HBV polymerase to reduce the content of episomal HBV DNA by reducing HBV messenger RNA transcription.
I have read and found that 90% of Terminalia cable ethanolic extracts are inhibited in the HBs antigen-binding assay and the HBV DNA polymerase inhibition assay.
In silico analysis of strong chemicals from Terminalia chebula have been shown to be effective in fighting the Hepatitis B virus.
In the HBs antigen-binding assay, the ethophicized ethanolic extraction of Terminalia cheb showed 60% high inhibition and aqueous extracts showed 55% inhibition and lamivudine control showed 60% inhibition.
Curcumin treatment has led to a reduction in dosage and time and dosage in HBsAg and HB